
Novartis to present new data from 34 abstracts in advanced prostate and early breast cancer at ESMO 2025
Novartis will present new data from 34 abstracts across its oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin (October




